Health Care SPDR (XLV) Stake Decreased by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. cut its position in shares of Health Care SPDR (NYSEARCA:XLV) by 6.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 152,745 shares of the exchange traded fund’s stock after selling 11,047 shares during the period. Cambridge Investment Research Advisors Inc. owned 0.08% of Health Care SPDR worth $12,629,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in XLV. JPMorgan Chase & Co. grew its stake in Health Care SPDR by 33.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 7,104,872 shares of the exchange traded fund’s stock valued at $577,269,000 after buying an additional 1,786,387 shares during the last quarter. Two Sigma Advisers LP grew its stake in Health Care SPDR by 54.4% in the 4th quarter. Two Sigma Advisers LP now owns 3,121,300 shares of the exchange traded fund’s stock valued at $258,069,000 after buying an additional 1,100,300 shares during the last quarter. Ameriprise Financial Inc. grew its stake in Health Care SPDR by 6.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,556,515 shares of the exchange traded fund’s stock valued at $208,846,000 after buying an additional 156,306 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Health Care SPDR by 14.2% in the 3rd quarter. Janney Montgomery Scott LLC now owns 1,679,910 shares of the exchange traded fund’s stock valued at $137,299,000 after buying an additional 208,955 shares during the last quarter. Finally, Lockheed Martin Investment Management Co. grew its stake in Health Care SPDR by 5.0% in the 4th quarter. Lockheed Martin Investment Management Co. now owns 1,541,985 shares of the exchange traded fund’s stock valued at $127,491,000 after buying an additional 74,095 shares during the last quarter.

How to Become a New Pot Stock Millionaire

XLV stock opened at $79.67 on Friday. Health Care SPDR has a 52 week low of $73.16 and a 52 week high of $91.79. The company has a market cap of $16,150.00 and a PE ratio of 6.17.

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 21st. Investors of record on Monday, March 19th were paid a $0.2997 dividend. The ex-dividend date was Friday, March 16th. This represents a $1.20 dividend on an annualized basis and a yield of 1.50%. Health Care SPDR’s dividend payout ratio (DPR) is currently 9.60%.

COPYRIGHT VIOLATION WARNING: This news story was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3295160/health-care-spdr-xlv-stake-decreased-by-cambridge-investment-research-advisors-inc.html.

About Health Care SPDR

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor’s 500 Composite Stock Index (S&P 500).

Want to see what other hedge funds are holding XLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Care SPDR (NYSEARCA:XLV).

Institutional Ownership by Quarter for Health Care SPDR (NYSEARCA:XLV)

Receive News & Ratings for Health Care SPDR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Care SPDR and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Astec Industries  Releases Quarterly  Earnings Results, Hits Expectations
Astec Industries Releases Quarterly Earnings Results, Hits Expectations
Equity Lifestyle Properties  Releases Q2 Earnings Guidance
Equity Lifestyle Properties Releases Q2 Earnings Guidance
Masco  Issues FY18 Earnings Guidance
Masco Issues FY18 Earnings Guidance
Head to Head Comparison: Byline Bancorp  vs. Its Rivals
Head to Head Comparison: Byline Bancorp vs. Its Rivals
EntreMed  Reaches New 1-Year High and Low at $7.61
EntreMed Reaches New 1-Year High and Low at $7.61
Analyzing Metso  & Kadant
Analyzing Metso & Kadant


© 2006-2018 Ticker Report. Google+.